首页> 外文期刊>Chinese neurosurgical journal. >Application of endoscopic endonasal approach in skull base surgeries: summary of 1886 cases in a single center for 10 consecutive years
【24h】

Application of endoscopic endonasal approach in skull base surgeries: summary of 1886 cases in a single center for 10 consecutive years

机译:内镜型内外方法在头骨基础手术中的应用:连续10年在单中心1886例中摘要

获取原文
       

摘要

Endonasal endoscopic skull base surgery has undergone rapid technological developments and is now widely performed, but its strengths and weaknesses deserve further investigation and deliberation. This study was performed to investigate the surgical indications, complications, and technical advantages and disadvantages of endonasal endoscopic skull base surgery. The clinical data of 1886 endoscopic endonasal skull base surgeries performed in our ward at Beijing Tiantan Hospital from June 2006 to June 2016 were retrospectively analyzed. One thousand ninety-three (73.4%, 1490) pituitary adenomas, 54 (24.9%, 217) chordomas, 28 (80.0%, 35) craniopharyngiomas, and 15 (83.3%, 18) meningiomas underwent total resection. Two patients died postoperatively, both having pituitary adenomas. Other postoperative complications included olfactory disorders (n = 226, 11.9%), postoperative cerebrospinal fluid leakage (n = 78, 4.1%), hypopituitarism (n = 74, 3.9%), diabetes insipidus (n = 64, 3.4%), intracranial infection (n = 36, 1.9%), epistaxis (n = 24, 1.3%), vascular injury (n = 8, 0.4%), optic nerve injury (n = 8, 0.4%), and oculomotor movement impairment (n = 4, 0.2%). In total, 1517 (80.4%) patients were followed up for 6 to 126?months (average, 42.5?months) postoperatively. A total of 196 (13.2%) pituitary adenomas and 13 (37.1%) craniopharyngiomas recurred but no meningiomas recurred. Chordomas recurred in 97 (44.7%) patients, in whom 5-year survival rate was 65%. Endoscopic surgery is an innovative surgical technique and the first choice for most midline extradural lesions such as chordomas, and an excellent choice for pituitary adenomas. It probably will be a good technique for many kinds of craniopharyngiomas and a common technique for most of skull base meningiomas, so the surgical indications of these cases should be chosen carefully to make good use of its respective advantages.
机译:内蒙古颅骨基础手术经历了快速的技术发展,现在已经广泛进行,但其优势和劣势值得进一步调查和审议。进行该研究以研究内和内窥镜颅脑脑脑脑脑脑基础手术的外科适应症,并发症和技术优势和缺点。回顾性分析了2006年6月至2016年6月在北京天坛医院在我们的病房中进行了1886年内窥镜内蒙古颅壳基地手术的临床资料。一千九十三(73.4%,1490)垂体腺瘤,54(24.9%,217)Chordomas,28(80.0%,35)颅粒细胞,15(83.3%,18)脑膜瘤进行总切除术。两名患者术后死亡,既具有垂体腺瘤。其他术后并发症包括嗅觉疾病(n = 226,11.9%),术后脑脊液泄漏(n = 78,4.1%),低钠缺陷(n = 74,3.9%),糖尿病insipidus(n = 64,3.4%),颅内感染(n = 36,1.9%),epistaxis(n = 24,1.3%),血管损伤(n = 8,0.4%),视神经损伤(n = 8,0.4%)和眼动脉运动损伤(n = 4,0.2%)。总共,术后,1517名(80.4%)患者术后持续了6至126岁?(平均42.5?月)。总共196名(13.2%)垂体腺瘤和13(37.1%)颅咽病重复,但没有脑膜瘤再次发生。 Chordomas重复于97名(44.7%)患者,其中5年生存率为65%。内镜手术是一种创新的手术技术,是奇异体瘤等大多数中线外损伤的首选,以及垂体腺瘤的绝佳选择。对于许多种类的颅咽管和大多数头骨基础脑膜瘤的常用技术可能是一种很好的技术,因此应仔细选择这些案例的手术指示,以良好地利用其各自的优势。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号